Loss of Ahi1 impairs neurotransmitter release and causes depressive behaviors in mice

PLoS One. 2014 Apr 1;9(4):e93640. doi: 10.1371/journal.pone.0093640. eCollection 2014.

Abstract

Major depression is becoming one of the most prevalent forms of psychiatric disorders. However, the mechanisms of major depression are still not well-understood. Most antidepressants are only effective in some patients and produce some serious side effects. Animal models of depression are therefore essential to unravel the mechanisms of depression and to develop novel therapeutic strategies. Our previous studies showed that Abelson helper integration site-1 (Ahi1) deficiency causes depression-like behaviors in mice. In this study, we characterized the biochemical and behavioral changes in Ahi1 knockout (KO) mice. In Ahi1 KO mice, neurotransmitters including serotonin and dopamine were significantly decreased in different brain regions. However, glutamate and GABA levels were not affected by Ahi1 deficiency. The antidepressant imipramine attenuated depressive behaviors and partially restored brain serotonin level in Ahi1 KO mice. Our findings suggest that Ahi1 KO mice can be used for studying the mechanisms of depression and screening therapeutic targets.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Vesicular Transport
  • Animals
  • Behavior, Animal*
  • Depressive Disorder, Major / drug therapy
  • Depressive Disorder, Major / genetics*
  • Depressive Disorder, Major / pathology
  • Dopamine / metabolism
  • Glutamic Acid / metabolism
  • Humans
  • Imipramine / administration & dosage
  • Mice
  • Mice, Knockout
  • Neurotransmitter Agents / genetics*
  • Neurotransmitter Agents / metabolism
  • Proto-Oncogene Proteins / genetics*
  • Serotonin / metabolism
  • gamma-Aminobutyric Acid / metabolism

Substances

  • Adaptor Proteins, Vesicular Transport
  • Ahi1 protein, mouse
  • Neurotransmitter Agents
  • Proto-Oncogene Proteins
  • Serotonin
  • Glutamic Acid
  • gamma-Aminobutyric Acid
  • Imipramine
  • Dopamine

Grants and funding

This study was supported by grants 81071095, 81120108011, and 813111078 (to XX) from the National Natural Science Foundation of China, Suzhou science and technology development program (SYS201232), the Priority Academic Program Development of Jiangsu Higher Education Institutions of China, Jiangsu Province’s Key Provincial Talents Program (to XX), and the National Basic Research Program of China (973 Program, 2013CB945401, to MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.